<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03962270</url>
  </required_header>
  <id_info>
    <org_study_id>M2018089</org_study_id>
    <nct_id>NCT03962270</nct_id>
  </id_info>
  <brief_title>Effect of Extracorporeal Shock Wave in the Treatment of Knee Osteoarthritis</brief_title>
  <official_title>Effect of Extracorporeal Shock Wave in the Treatment of Knee Osteoarthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University Third Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the effectiveness of ESWT in the treatment of knee OA was investigated from
      the perspective of cartilage injury，and to prove that shockwave could delay the early and
      middle stage OA progression by improving cartilage condition
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2018</start_date>
  <completion_date type="Anticipated">August 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>magnetic resonance imaging of knee</measure>
    <time_frame>Baseline (before treatment)</time_frame>
    <description>t2 mapping</description>
  </primary_outcome>
  <primary_outcome>
    <measure>magnetic resonance imaging of knee</measure>
    <time_frame>Three months after treatment</time_frame>
    <description>t2 mapping</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Knee Osteoarthritis</condition>
  <condition>Cartilage Injury</condition>
  <arm_group>
    <arm_group_label>Treatment group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>shock wave device</intervention_name>
    <description>The experimental group (group ESWT) guided by ultrasound: conventional rehabilitation training is given priority to with strength training, application of pain when necessary, under the guidance of ultrasound ESWT treatment control group (routine rehabilitation group) : conventional rehabilitation training is given priority to with strength training, oral pain when necessary, under the guidance of ultrasound ESWT treatment (shock energy flow density of 0)</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Treatment group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Knee joint ROM normal or near normal: flexion 110 ° or reach 0 ° or less

          -  MR prompt exist cartilage damage, there is no lack of full-thickness cartilage

          -  Kellgren - Lawrence (K - L) grade II - III grade

          -  The international association of cartilage repair cartilage damage grading system
             (ICRS) class I - III

          -  Informed consent and sign relevant documents

          -  Follow doctor's instructions and follow up on time

        Exclusion Criteria:

          -  Metabolic arthritis

          -  Trauma of bone joint

          -  Inflammatory diseases

          -  Previous knee surgery history

          -  History of knee cavity injection in the past 6 months

          -  Serious cardiovascular diseases, pulmonary diseases or other serious diseases
             affecting survival, etc
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>mouwang 谋望 zhou, master</last_name>
    <phone>13910092892</phone>
    <phone_ext>周</phone_ext>
    <email>zhoumouwang@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>mingzhen 明真 Lee, bachelor</last_name>
    <phone>18810334425</phone>
    <phone_ext>李</phone_ext>
    <email>mingzhenli@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Peking Univercity Third Hospital</name>
      <address>
        <city>Beijing</city>
        <state>No State Or Province</state>
        <zip>100191</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Mingzhen Li, bachelor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>October 30, 2018</study_first_submitted>
  <study_first_submitted_qc>May 23, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 24, 2019</study_first_posted>
  <last_update_submitted>May 23, 2019</last_update_submitted>
  <last_update_submitted_qc>May 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking University Third Hospital</investigator_affiliation>
    <investigator_full_name>Mouwang Zhou</investigator_full_name>
    <investigator_title>senior professional post</investigator_title>
  </responsible_party>
  <keyword>Extracorporeal Shock Wave Therapy</keyword>
  <keyword>Knee Osteoarthritis</keyword>
  <keyword>Cartilage Injury</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

